A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT01992653 · COMPLETED
Trial details
- NCT number
- NCT01992653
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-29
- Primary completion
- 2018-12-19
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.